 | • レポートコード：QYR2104Z4639 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、血漿分画のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロテアーゼ阻害剤、プロテアーゼ、線維素溶解タンパク質、凝固因子、抗凝固タンパク質）、用途別市場規模（病院、診療所、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・血漿分画の市場動向 ・企業の競争状況、市場シェア ・血漿分画の種類別市場規模（プロテアーゼ阻害剤、プロテアーゼ、線維素溶解タンパク質、凝固因子、抗凝固タンパク質） ・血漿分画の用途別市場規模（病院、診療所、外来手術センター） ・血漿分画の北米市場規模2016-2027（アメリカ、カナダ） ・血漿分画のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・血漿分画のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血漿分画の中南米市場規模2016-2027（メキシコ、ブラジル） ・血漿分画の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Baxter、Octapharma、Biotest、CSL、Grifols、Kedrion、LFB、Chinese Biological Products、Shanghai RAAS Blood Products） ・結論 |
Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation.
Increasing awareness about the disease and increasing disposable income are expected to boost the growth of the plasma fraction market.
Market Analysis and Insights: Global Plasma Fraction Market
The global Plasma Fraction market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Plasma Fraction market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Plasma Fraction market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Plasma Fraction market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Plasma Fraction market.
Global Plasma Fraction Scope and Market Size
Plasma Fraction market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Fraction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Protease Inhibitors
Protease
Fibrinolytic Proteins
Coagulation Factors
Anti-Coagulant Proteins
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Baxter
Octapharma
Biotest
CSL
Grifols
Kedrion
LFB
Chinese Biological Products
Shanghai RAAS Blood Products
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Fraction Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Protease Inhibitors
1.2.3 Protease
1.2.4 Fibrinolytic Proteins
1.2.5 Coagulation Factors
1.2.6 Anti-Coagulant Proteins
1.3 Market by Application
1.3.1 Global Plasma Fraction Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasma Fraction Market Perspective (2016-2027)
2.2 Plasma Fraction Growth Trends by Regions
2.2.1 Plasma Fraction Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Plasma Fraction Historic Market Share by Regions (2016-2021)
2.2.3 Plasma Fraction Forecasted Market Size by Regions (2022-2027)
2.3 Plasma Fraction Industry Dynamic
2.3.1 Plasma Fraction Market Trends
2.3.2 Plasma Fraction Market Drivers
2.3.3 Plasma Fraction Market Challenges
2.3.4 Plasma Fraction Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Fraction Players by Revenue
3.1.1 Global Top Plasma Fraction Players by Revenue (2016-2021)
3.1.2 Global Plasma Fraction Revenue Market Share by Players (2016-2021)
3.2 Global Plasma Fraction Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Plasma Fraction Revenue
3.4 Global Plasma Fraction Market Concentration Ratio
3.4.1 Global Plasma Fraction Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Fraction Revenue in 2020
3.5 Plasma Fraction Key Players Head office and Area Served
3.6 Key Players Plasma Fraction Product Solution and Service
3.7 Date of Enter into Plasma Fraction Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Fraction Breakdown Data by Type
4.1 Global Plasma Fraction Historic Market Size by Type (2016-2021)
4.2 Global Plasma Fraction Forecasted Market Size by Type (2022-2027)
5 Plasma Fraction Breakdown Data by Application
5.1 Global Plasma Fraction Historic Market Size by Application (2016-2021)
5.2 Global Plasma Fraction Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Plasma Fraction Market Size (2016-2027)
6.2 North America Plasma Fraction Market Size by Type
6.2.1 North America Plasma Fraction Market Size by Type (2016-2021)
6.2.2 North America Plasma Fraction Market Size by Type (2022-2027)
6.2.3 North America Plasma Fraction Market Size by Type (2016-2027)
6.3 North America Plasma Fraction Market Size by Application
6.3.1 North America Plasma Fraction Market Size by Application (2016-2021)
6.3.2 North America Plasma Fraction Market Size by Application (2022-2027)
6.3.3 North America Plasma Fraction Market Size by Application (2016-2027)
6.4 North America Plasma Fraction Market Size by Country
6.4.1 North America Plasma Fraction Market Size by Country (2016-2021)
6.4.2 North America Plasma Fraction Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Plasma Fraction Market Size (2016-2027)
7.2 Europe Plasma Fraction Market Size by Type
7.2.1 Europe Plasma Fraction Market Size by Type (2016-2021)
7.2.2 Europe Plasma Fraction Market Size by Type (2022-2027)
7.2.3 Europe Plasma Fraction Market Size by Type (2016-2027)
7.3 Europe Plasma Fraction Market Size by Application
7.3.1 Europe Plasma Fraction Market Size by Application (2016-2021)
7.3.2 Europe Plasma Fraction Market Size by Application (2022-2027)
7.3.3 Europe Plasma Fraction Market Size by Application (2016-2027)
7.4 Europe Plasma Fraction Market Size by Country
7.4.1 Europe Plasma Fraction Market Size by Country (2016-2021)
7.4.2 Europe Plasma Fraction Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Plasma Fraction Market Size (2016-2027)
8.2 Asia-Pacific Plasma Fraction Market Size by Type
8.2.1 Asia-Pacific Plasma Fraction Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Plasma Fraction Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Plasma Fraction Market Size by Type (2016-2027)
8.3 Asia-Pacific Plasma Fraction Market Size by Application
8.3.1 Asia-Pacific Plasma Fraction Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Plasma Fraction Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Plasma Fraction Market Size by Application (2016-2027)
8.4 Asia-Pacific Plasma Fraction Market Size by Region
8.4.1 Asia-Pacific Plasma Fraction Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Plasma Fraction Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Plasma Fraction Market Size (2016-2027)
9.2 Latin America Plasma Fraction Market Size by Type
9.2.1 Latin America Plasma Fraction Market Size by Type (2016-2021)
9.2.2 Latin America Plasma Fraction Market Size by Type (2022-2027)
9.2.3 Latin America Plasma Fraction Market Size by Type (2016-2027)
9.3 Latin America Plasma Fraction Market Size by Application
9.3.1 Latin America Plasma Fraction Market Size by Application (2016-2021)
9.3.2 Latin America Plasma Fraction Market Size by Application (2022-2027)
9.3.3 Latin America Plasma Fraction Market Size by Application (2016-2027)
9.4 Latin America Plasma Fraction Market Size by Country
9.4.1 Latin America Plasma Fraction Market Size by Country (2016-2021)
9.4.2 Latin America Plasma Fraction Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Fraction Market Size (2016-2027)
10.2 Middle East & Africa Plasma Fraction Market Size by Type
10.2.1 Middle East & Africa Plasma Fraction Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Plasma Fraction Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Plasma Fraction Market Size by Type (2016-2027)
10.3 Middle East & Africa Plasma Fraction Market Size by Application
10.3.1 Middle East & Africa Plasma Fraction Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Plasma Fraction Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Plasma Fraction Market Size by Application (2016-2027)
10.4 Middle East & Africa Plasma Fraction Market Size by Country
10.4.1 Middle East & Africa Plasma Fraction Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Plasma Fraction Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Baxter Business Overview
11.1.3 Baxter Plasma Fraction Introduction
11.1.4 Baxter Revenue in Plasma Fraction Business (2016-2021)
11.1.5 Baxter Recent Development
11.2 Octapharma
11.2.1 Octapharma Company Details
11.2.2 Octapharma Business Overview
11.2.3 Octapharma Plasma Fraction Introduction
11.2.4 Octapharma Revenue in Plasma Fraction Business (2016-2021)
11.2.5 Octapharma Recent Development
11.3 Biotest
11.3.1 Biotest Company Details
11.3.2 Biotest Business Overview
11.3.3 Biotest Plasma Fraction Introduction
11.3.4 Biotest Revenue in Plasma Fraction Business (2016-2021)
11.3.5 Biotest Recent Development
11.4 CSL
11.4.1 CSL Company Details
11.4.2 CSL Business Overview
11.4.3 CSL Plasma Fraction Introduction
11.4.4 CSL Revenue in Plasma Fraction Business (2016-2021)
11.4.5 CSL Recent Development
11.5 Grifols
11.5.1 Grifols Company Details
11.5.2 Grifols Business Overview
11.5.3 Grifols Plasma Fraction Introduction
11.5.4 Grifols Revenue in Plasma Fraction Business (2016-2021)
11.5.5 Grifols Recent Development
11.6 Kedrion
11.6.1 Kedrion Company Details
11.6.2 Kedrion Business Overview
11.6.3 Kedrion Plasma Fraction Introduction
11.6.4 Kedrion Revenue in Plasma Fraction Business (2016-2021)
11.6.5 Kedrion Recent Development
11.7 LFB
11.7.1 LFB Company Details
11.7.2 LFB Business Overview
11.7.3 LFB Plasma Fraction Introduction
11.7.4 LFB Revenue in Plasma Fraction Business (2016-2021)
11.7.5 LFB Recent Development
11.8 Chinese Biological Products
11.8.1 Chinese Biological Products Company Details
11.8.2 Chinese Biological Products Business Overview
11.8.3 Chinese Biological Products Plasma Fraction Introduction
11.8.4 Chinese Biological Products Revenue in Plasma Fraction Business (2016-2021)
11.8.5 Chinese Biological Products Recent Development
11.9 Shanghai RAAS Blood Products
11.9.1 Shanghai RAAS Blood Products Company Details
11.9.2 Shanghai RAAS Blood Products Business Overview
11.9.3 Shanghai RAAS Blood Products Plasma Fraction Introduction
11.9.4 Shanghai RAAS Blood Products Revenue in Plasma Fraction Business (2016-2021)
11.9.5 Shanghai RAAS Blood Products Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Plasma Fraction Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Protease Inhibitors
Table 3. Key Players of Protease
Table 4. Key Players of Fibrinolytic Proteins
Table 5. Key Players of Coagulation Factors
Table 6. Key Players of Anti-Coagulant Proteins
Table 7. Global Plasma Fraction Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Plasma Fraction Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Plasma Fraction Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Plasma Fraction Market Share by Regions (2016-2021)
Table 11. Global Plasma Fraction Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Plasma Fraction Market Share by Regions (2022-2027)
Table 13. Plasma Fraction Market Trends
Table 14. Plasma Fraction Market Drivers
Table 15. Plasma Fraction Market Challenges
Table 16. Plasma Fraction Market Restraints
Table 17. Global Plasma Fraction Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Plasma Fraction Market Share by Players (2016-2021)
Table 19. Global Top Plasma Fraction Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Fraction as of 2020)
Table 20. Ranking of Global Top Plasma Fraction Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Plasma Fraction Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Plasma Fraction Product Solution and Service
Table 24. Date of Enter into Plasma Fraction Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Plasma Fraction Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Plasma Fraction Revenue Market Share by Type (2016-2021)
Table 28. Global Plasma Fraction Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Plasma Fraction Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Plasma Fraction Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Plasma Fraction Revenue Market Share by Application (2016-2021)
Table 32. Global Plasma Fraction Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Plasma Fraction Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Plasma Fraction Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Plasma Fraction Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Plasma Fraction Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Plasma Fraction Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Plasma Fraction Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Plasma Fraction Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Plasma Fraction Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Plasma Fraction Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Plasma Fraction Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Plasma Fraction Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Plasma Fraction Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Plasma Fraction Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Plasma Fraction Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Plasma Fraction Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Plasma Fraction Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Plasma Fraction Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Plasma Fraction Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Plasma Fraction Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Plasma Fraction Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Plasma Fraction Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Plasma Fraction Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Plasma Fraction Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Plasma Fraction Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Plasma Fraction Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Plasma Fraction Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Plasma Fraction Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Plasma Fraction Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Plasma Fraction Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Plasma Fraction Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Plasma Fraction Market Size by Country (2022-2027) & (US$ Million)
Table 64. Baxter Company Details
Table 65. Baxter Business Overview
Table 66. Baxter Plasma Fraction Product
Table 67. Baxter Revenue in Plasma Fraction Business (2016-2021) & (US$ Million)
Table 68. Baxter Recent Development
Table 69. Octapharma Company Details
Table 70. Octapharma Business Overview
Table 71. Octapharma Plasma Fraction Product
Table 72. Octapharma Revenue in Plasma Fraction Business (2016-2021) & (US$ Million)
Table 73. Octapharma Recent Development
Table 74. Biotest Company Details
Table 75. Biotest Business Overview
Table 76. Biotest Plasma Fraction Product
Table 77. Biotest Revenue in Plasma Fraction Business (2016-2021) & (US$ Million)
Table 78. Biotest Recent Development
Table 79. CSL Company Details
Table 80. CSL Business Overview
Table 81. CSL Plasma Fraction Product
Table 82. CSL Revenue in Plasma Fraction Business (2016-2021) & (US$ Million)
Table 83. CSL Recent Development
Table 84. Grifols Company Details
Table 85. Grifols Business Overview
Table 86. Grifols Plasma Fraction Product
Table 87. Grifols Revenue in Plasma Fraction Business (2016-2021) & (US$ Million)
Table 88. Grifols Recent Development
Table 89. Kedrion Company Details
Table 90. Kedrion Business Overview
Table 91. Kedrion Plasma Fraction Product
Table 92. Kedrion Revenue in Plasma Fraction Business (2016-2021) & (US$ Million)
Table 93. Kedrion Recent Development
Table 94. LFB Company Details
Table 95. LFB Business Overview
Table 96. LFB Plasma Fraction Product
Table 97. LFB Revenue in Plasma Fraction Business (2016-2021) & (US$ Million)
Table 98. LFB Recent Development
Table 99. Chinese Biological Products Company Details
Table 100. Chinese Biological Products Business Overview
Table 101. Chinese Biological Products Revenue in Plasma Fraction Business (2016-2021) & (US$ Million)
Table 102. Chinese Biological Products Recent Development
Table 103. Shanghai RAAS Blood Products Company Details
Table 104. Shanghai RAAS Blood Products Business Overview
Table 105. Shanghai RAAS Blood Products Plasma Fraction Product
Table 106. Shanghai RAAS Blood Products Revenue in Plasma Fraction Business (2016-2021) & (US$ Million)
Table 107. Shanghai RAAS Blood Products Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Fraction Market Share by Type: 2020 VS 2027
Figure 2. Protease Inhibitors Features
Figure 3. Protease Features
Figure 4. Fibrinolytic Proteins Features
Figure 5. Coagulation Factors Features
Figure 6. Anti-Coagulant Proteins Features
Figure 7. Global Plasma Fraction Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Plasma Fraction Report Years Considered
Figure 12. Global Plasma Fraction Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Plasma Fraction Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Plasma Fraction Market Share by Regions: 2020 VS 2027
Figure 15. Global Plasma Fraction Market Share by Regions (2022-2027)
Figure 16. Global Plasma Fraction Market Share by Players in 2020
Figure 17. Global Top Plasma Fraction Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Fraction as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Plasma Fraction Revenue in 2020
Figure 19. Global Plasma Fraction Revenue Market Share by Type (2016-2021)
Figure 20. Global Plasma Fraction Revenue Market Share by Type (2022-2027)
Figure 21. North America Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Plasma Fraction Market Share by Type (2016-2027)
Figure 23. North America Plasma Fraction Market Share by Application (2016-2027)
Figure 24. North America Plasma Fraction Market Share by Country (2016-2027)
Figure 25. United States Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Plasma Fraction Market Share by Type (2016-2027)
Figure 29. Europe Plasma Fraction Market Share by Application (2016-2027)
Figure 30. Europe Plasma Fraction Market Share by Country (2016-2027)
Figure 31. Germany Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Plasma Fraction Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Plasma Fraction Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Plasma Fraction Market Share by Region (2016-2027)
Figure 41. China Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Plasma Fraction Market Share by Type (2016-2027)
Figure 49. Latin America Plasma Fraction Market Share by Application (2016-2027)
Figure 50. Latin America Plasma Fraction Market Share by Country (2016-2027)
Figure 51. Mexico Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Plasma Fraction Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Plasma Fraction Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Plasma Fraction Market Share by Country (2016-2027)
Figure 57. Turkey Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Plasma Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Baxter Revenue Growth Rate in Plasma Fraction Business (2016-2021)
Figure 61. Octapharma Revenue Growth Rate in Plasma Fraction Business (2016-2021)
Figure 62. Biotest Revenue Growth Rate in Plasma Fraction Business (2016-2021)
Figure 63. CSL Revenue Growth Rate in Plasma Fraction Business (2016-2021)
Figure 64. Grifols Revenue Growth Rate in Plasma Fraction Business (2016-2021)
Figure 65. Kedrion Revenue Growth Rate in Plasma Fraction Business (2016-2021)
Figure 66. LFB Revenue Growth Rate in Plasma Fraction Business (2016-2021)
Figure 67. Chinese Biological Products Revenue Growth Rate in Plasma Fraction Business (2016-2021)
Figure 68. Shanghai RAAS Blood Products Revenue Growth Rate in Plasma Fraction Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の血漿プロテアーゼC1阻害剤治療市場規模・現状・予測（2021年-2027年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…- 世界の間質血管分画市場規模・現状・予測（2021年-2027年） Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient’s own body. With increasing age, regenerative and repair properties of skin are less effective due to decrease in stem cell count, …
- 世界の組換え治療用抗体＆タンパク質市場規模・現状・予測（2021年-2027年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
- 世界の血小板＆血漿市場規模・現状・予測（2021年-2027年） Platelets, also called thrombocytes, are a component of blood whose function (along with the coagulation factors) is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot. Plasma is a yellowish coloured liquid component of blood that normally holds the blood cell…
- 世界の血小板＆血漿市場規模・現状・予測（2021年-2027年） Platelets, also called thrombocytes, are a component of blood whose function (along with the coagulation factors) is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot. Plasma is a yellowish coloured liquid component of blood that normally holds the blood cell…